ArticleHemaSphere2025
Working towards harmonization of clinical trial reporting in Hodgkin lymphoma.
Carsten Kobe, Philippe Armand, Sven Borchmann, Graham P Collins, Anne-Segolene Cottereau, Justin Ferdinandus, Alex F Herrera, Davide Rossi, Wouter J Plattel, Sally F Barrington and 1 more
Abstract read
In one paragraphArticle in HemaSphere, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Philippe ArmandDepartment of Medical Oncology Dana-Farber Cancer Institute Boston Massachusetts USA.
Sven BorchmannDepartment I of Internal Medicine Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), Faculty of Medicine and University Hospital of Cologne University of Cologne Cologne Germany.
Graham P CollinsOxford Cancer and Haematology Centre, Churchill Hospital Oxford UK.
Anne-Segolene CottereauDepartment of Nuclear Medicine Cochin Hospital, AP-HP University of Paris Cité Paris France.
Justin FerdinandusDepartment I of Internal Medicine Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD) and German Hodgkin Study Group (GHSG), Faculty of Medicine and University Hospital of Cologne University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0002-3481-7997 Alex F HerreraDepartment of Hematology & Hematopoietic Cell Transplantation City of Hope Duarte California USA.
Davide RossiDepartment of Oncology Institute of Oncology Research Bellinzona Switzerland.
Wouter J PlattelDepartment of Hematology University Medical Center Groningen University of Groningen Groningen The Netherlands.
Sally F BarringtonSchool of Biomedical Engineering and Imaging Sciences, King's College London and Guy's and St Thomas' PET Centre, King's College London, King's Health Partners London UK.
Martin HutchingsDepartment of Hematology Rigshospitalet University of Copenhagen Copenhagen Denmark.
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID40785980
PMCPMC12331867
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390